TGTX icon

TG Therapeutics

254 hedge funds and large institutions have $1.67B invested in TG Therapeutics in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 92 increasing their positions, 67 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
254
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49M
Puts
$35.3M
Net Calls
Net Calls Change

Top Buyers

1 +$51.1M
2 +$36.5M
3 +$19.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$14.3M
5
Goldman Sachs
Goldman Sachs
New York
+$14.2M

Top Sellers

1 -$54.9M
2 -$36M
3 -$19.6M
4
VPC
Vestal Point Capital
New York
-$16M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.45M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.2M
102
$1.16M
103
$1.15M
104
$1.11M
105
$1.08M
106
$1.06M
107
$1.03M
108
$1.01M
109
$999K
110
$976K
111
$950K
112
$947K
113
$946K
114
$931K
115
$920K
116
$888K
117
$833K
118
$833K
119
$827K
120
$801K
121
$801K
122
$767K
123
$764K
124
$753K
125
$734K